JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ginzel, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ginzel, K. H.
Journal of Pharmacology And Experimental Therapeutics, Vol. 154, Issue 1, 128-141, 1966
Copyright © 1966 by American Society for Pharmacology and Experimental Therapeutics


THE BLOCKADE OF RETICULAR AND SPINAL FACILITATION OF MOTOR FUNCTION BY ORPHENADRINE

K. H. Ginzel 1

1 Biological Sciences Section, Riker Laboratories, Northridge, California

The effect of orphenadrine on motor systems was studied in anesthetized, spinal and decerebrate cats. Orphenadrine was found to block facilitation of the knee jerk induced by electrical stimulation of the facilitatory reticular formation or the contralateral sciatic nerve. This blockade occurred at a dose which did not block inhibition of the reflex induced by stimulation of inhibitory reticular, cerebellar, caudate or cortical regions or the ipsilateral sciatic nerve. Orphenadrine also relieved the increased extensor tonus and clonus in cats decerebrated by intercollicular section. The action does not depend on the presence of an anesthetic such as chloralose or pentobarbital and is not secondary to gross cardiovascular effects. The anticholinergic and antihistaminic properties of the drug are not likely to play an essential role in its blocking effect on facilitation or decerebrate rigidity. Conversely, cholinergic synapses are not likely to be present within the facilitatory reticulospinal pathway. The evidence presented provides a basis for the understanding of the efficacy of orphenadrine in various forms of skeletal muscle spasm and prompts the classification of the drug as a centrally acting muscle relaxant. The possible site and mechanism of the antifacilitatory action of orphenadrine is discussed.

Submitted on November 5, 1965
Accepted on April 25, 1966







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics.